KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) EBT (2017 - 2025)

Elanco Animal Health's EBT history spans 9 years, with the latest figure at -$259.0 million for Q4 2025.

  • For Q4 2025, EBT fell 407.84% year-over-year to -$259.0 million; the TTM value through Dec 2025 reached -$224.0 million, down 145.9%, while the annual FY2025 figure was -$224.0 million, 145.9% down from the prior year.
  • EBT for Q4 2025 was -$259.0 million at Elanco Animal Health, down from -$50.0 million in the prior quarter.
  • Across five years, EBT topped out at $559.0 million in Q3 2024 and bottomed at -$1.1 billion in Q3 2023.
  • The 5-year median for EBT is -$50.5 million (2024), against an average of -$78.6 million.
  • The largest annual shift saw EBT crashed 2393.18% in 2023 before it skyrocketed 400.0% in 2025.
  • A 5-year view of EBT shows it stood at -$120.0 million in 2021, then rose by 25.83% to -$89.0 million in 2022, then crashed by 42.7% to -$127.0 million in 2023, then skyrocketed by 59.84% to -$51.0 million in 2024, then crashed by 407.84% to -$259.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's EBT are -$259.0 million (Q4 2025), -$50.0 million (Q3 2025), and $25.0 million (Q2 2025).